Adam K. Simpson - Jan 25, 2023 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Jan 25, 2023
Transactions value $
$13,117
Form type
4
Date filed
1/27/2023, 04:02 PM
Previous filing
Dec 23, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $2.01K +2.4K +1% $0.84* 242K Jan 25, 2023 Direct
transaction ICVX Common Stock Options Exercise $11.1K +10.7K +4.41% $1.04* 253K Jan 25, 2023 Direct
holding ICVX Common Stock 532K Jan 25, 2023 By family trust
holding ICVX Common Stock 129K Jan 25, 2023 By family trust
holding ICVX Common Stock 129K Jan 25, 2023 By family trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -2.4K -7.14% $0.00 31.1K Jan 25, 2023 Common Stock 2.4K $0.84 Direct F1
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -10.7K -2.43% $0.00 428K Jan 25, 2023 Common Stock 10.7K $1.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 2/21/2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F2 25% of the shares subject to the option vested on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.